Infliximab improves psoriasis regardless of arthritis response in patients with active psoriatic arthritis: Results from the IMPACT 2 trial.

被引：0
|
作者：
Mease, P
Kavanaugh, A
Krueger, GG
Shergy, W
Halter, D
De Vlam, K
Kirkham, B
Bala, M
Beutlers, A
Guzzo, C
Zhou, B
Dooley, L
Antoni, C
机构：
[1] Seattle Rheumatol Associates, Swedish Med Ctr, Seattle, WA USA
[2] UCSD, Div Rheumatol Allergy & Immunol, San Diego, CA USA
[3] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
[4] Rheumatol Associates N Alabama, Huntsville, AL USA
[5] Houston Clin Res, Houston, TX USA
[6] Univ Hosp KU, Louvain, Belgium
[7] Guys & St Thomas Hosp, Dept Rheumatol, London, England
[8] Centocor Inc, Malvern, PA 19355 USA
[9] Univ Erlangen Nurnberg, Erlangen, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S616 / S616
页数：1
相关论文
共 50 条
  • [1] Infliximab improves arthritis and psoriasis in patients with active polyarticular psoriatic arthritis: Results of the impact 2 trial
    Kavanaugh, A
    Krueger, GG
    De Vlam, K
    Birbara, C
    Beutler, A
    Guzzo, C
    Zhou, B
    DeWoody, K
    Antoni, C
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
  • [2] Infliximab improves skin involvement in psoriatic arthritis regardless of baseline psoriasis severity: Subanalysis of skin response from the IMPACT 2 trial
    Papp, K
    Joshi, S
    Guzzo, C
    Krueger, G
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P188 - P188
  • [3] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
    Antoni, C
    Krueger, GG
    de Vlam, K
    Birbara, C
    Beutler, A
    Guzzo, C
    Zhou, B
    Dooley, LT
    Kavanaugh, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1150 - 1157
  • [4] Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis: Results from IMPACT 2 trial
    Van der Heljde, D
    Kavanaugh, A
    Beutler, A
    Guzzo, C
    Zhou, B
    Dooley, L
    Antonl, CE
    Krueger, GG
    Gladman, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 109 - 109
  • [5] Infliximab improves signs of plaque psoriasis in patients with psoriatic arthritis
    Gottlieb, AB
    Evans, R
    Patel, K
    Matheson, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P157 - P157
  • [6] Infliximab improves signs of plaque psoriasis in patients with psoriatic arthritis.
    Menter, A
    Evans, R
    Dooley, LT
    Patel, K
    Guzzo, C
    Matheson, R
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S167 - S167
  • [7] 2-year data: Infliximab maintains clinical response in psoriatic arthritis patients-data from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni, CE
    Kavanaugh, A
    Kirkham, B
    Tutuncu, ZN
    Burmester, G
    Schneider, U
    Furst, DE
    Moliter, J
    Keystone, EC
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, D
    Weisman, M
    Kalden, JR
    Smolen, JS
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S209 - S209
  • [8] Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial
    Kavanaugh, A.
    Krueger, G. G.
    Beutler, A.
    Guzzo, C.
    Zhou, B.
    Dooley, L. T.
    Mease, P. J.
    Gladman, D. D.
    de Vlam, K.
    Geusens, P. P.
    Birbara, C.
    Halter, D. G.
    Antoni, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 498 - 505
  • [9] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
    Antoni, CE
    Kavanagh, A
    Kirkham, B
    Tutuncu, Z
    Burmester, GR
    Schneider, U
    Furst, DE
    Molitor, J
    Keystone, E
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, DJ
    Weisman, MH
    Kalden, JR
    Smolen, J
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1227 - 1236
  • [10] Infliximab results in functional status improvement in patients with active psoriatic arthritis regardless of baseline radiographic damage severity - 1-year results from IMPACT 2
    Kavanaugh, A.
    Krueger, G. G.
    de Vlam, K.
    Birbara, C.
    Beutler, A.
    Zhou, B.
    Dooley, L. T.
    Guzzo, C.
    Bala, M.
    Kirkham, B.
    Antoni, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 418 - 418
12345